ArticlePrimary care companion to the Journal of clinical psychiatry2006
Psychiatric disease and hypercholesterolemia in an urban academic primary care clinic.
Article in Primary care companion to the Journal of clinical psychiatry, 2006. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed, 0 citations in OpenAlex.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors at 3 institutions in 1 country.
Funding
Abstract
backgroundThere are limited data regarding the quality of cardiovascular risk reduction in primary care settings with a high prevalence of psychiatric disease.
objectiveTo determine if there are differences in the rates of testing and treatment for hypercholesterolemia between patients with and without psychiatric disease. STUDY
designCross-sectional chart review. PATIENTS: 197 adult patients of a hospital-based, academic primary care clinic.
methodMedical records were reviewed for demographic information, documented psychiatric disease, cardiovascular risk factors, prescription for cholesterol-lowering medication, and a serum total cholesterol result within 5 years of the most recent clinic visit.
resultsSubjects with (N = 76) and without (N = 121) psychiatric disease had similar clinical and demographic characteristics (all p > .05) as well as rates of cholesterol testing (92% vs. 93%, p = .91). Neither diagnosis of hypercholesterolemia nor prescription for cholesterol-lowering medication were associated with psychiatric disease (p = 1.00 and p = .34, respectively). The mean serum total cholesterol was 15 mg/dL higher for patients with psychiatric disease than for those without (p = .016).
conclusionIn this patient population, the presence of psychiatric disease was not associated with differential rates of hypercholesterolemia testing, diagnosis, or treatment. We observed higher mean serum total cholesterol levels in subjects with psychiatric disease. Further study is needed to examine the implications of our findings.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.